Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SuperStarch is a proprietary, high-molecular-weight complex carbohydrate produced from non-GMO corn through a specialized hydrothermal treatment process. Originally engineered to provide a long-lasting source of glucose for children with Glycogen Storage Disease (GSD) to prevent nocturnal hypoglycemia, it has since been commercialized for sports nutrition and metabolic health. The hydrothermal modification alters the starch's physical structure, making it highly resistant to rapid enzymatic hydrolysis by alpha-amylase. Consequently, SuperStarch is absorbed slowly in the gastrointestinal tract, providing a sustained release of energy over several hours with a minimal impact on insulin levels. This unique pharmacokinetic profile supports stable blood glucose and enhances lipid oxidation during physical activity, making it a preferred energy source for endurance athletes and individuals managing metabolic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SuperStarch.